GlaxoSmithKline PLC — Director's Dealing 2016

Feb 16, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2466P

GlaxoSmithKline PLC

16 February 2016

GlaxoSmithKline plc

Notification of Transactions of Directors and Persons Discharging Managerial   Responsibility

GlaxoSmithKline Performance Share Plan

Sale of shares to meet tax liabilities

The table below sets out changes in the interests of Directors and Persons Discharging Managerial Responsibilities ('PDMR') in the Ordinary Shares of GlaxoSmithKline plc arising from the sale of Ordinary Shares at a fair market value price of £14.06 per Ordinary Share on 12 February 2016 to meet tax liabilities following the vesting of awards granted in 2012 under the GlaxoSmithKline 2009 Performance Share Plan ('PSP').

Director/PDMR	Number of Ordinary Shares sold to meet tax liabilities following the vesting of a PSP award
Sir Andrew Witty*	68,158
Mr S Dingemans*	39,987
Mr R Connor	17,134
Mr A Hussain	24,104
Mr D Redfern	13,136
Ms C Thomas	18,562
Mr P Thomson	8,853
Dr P Vallance	39,979
Ms E Walmsley	22,845
Mrs VA Whyte**	2,451

* Denotes an Executive Director

** Sale for tax of vested PSP awards granted under the non CET Performance Share Plan

The table below sets out changes in the interests of PDMRs in the American Depositary Shares ('ADS') of GlaxoSmithKline plc arising from the withholding of ADSs at a closing share price of $39.15 per ADS on 12 February 2016 to establish the fair market value to meet tax liabilities following the vesting of awards granted in 2012 under the PSP.

Director/PDMR	Number of ADSs withheld to meet tax liabilities following the vesting of a PSP award
Dr M Slaoui*	26,557
Mr N Hirons**	1,390
Mr D Troy	16,364

* Denotes an Executive Director

** Sale for tax of vested PSP awards granted under the non CET Performance Share Plan

The Company, Directors and PDMRs were advised of these transactions on 16 February 2016.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

16 February 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQQLFFQLFFBBL